VP, Head of Cell & Genetic Medicines Discovery

MeiraGTx Reports Second Quarter 2025 Financial and Operational Results

Interleukin-23 Inhibitors Market to Surge During the Forecast Period (2025-2034) Due to Demand for Targeted Autoimmune Therapies | DelveInsight

Urothelial Carcinoma Market Set to Expand During the Forecast Period (2025-2034) Amid Rising Incidence and Evolving Therapeutic Landscape | DelveInsight

Johnson & Johnson Innovative Medicine’s Tremfya Gains Momentum in Crohn’s Disease, Outpacing Eli Lilly’s Omvoh and Challenging AbbVie’s Skyrizi

Sr. Specialist Vein to Vein Supply Chain CAR-T

Johnson & Johnson Innovative Medicine is dedicated to healthcare innovation, aiming to prevent, treat, and cure complex diseases. They are seeking a Sr. Specialist Vein to Vein Supply Chain CAR-T to support the patient journey by managing supply chain processes for CAR-T therapies, ensuring effective communication and collaboration with various teams throughout the treatment process.

Sign up with Google

Sign in with Google